Stay updated on Cabozantinib in Advanced Solid Malignancies Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Advanced Solid Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Advanced Solid Malignancies Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T20:28:25.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update or modification in the information related to the Phase II clinical trial of Cabozantinib in treating cancer that has spread to the bone, specifically focusing on patients with advanced solid malignancies and bony metastases.
    Difference
    0.1%
    Check dated 2024-06-06T14:18:08.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying that researchers are looking for participants with a histologic or cytologic diagnosis of a solid tumor (excluding breast or prostate) that is metastatic and has progressed following standard therapies. The new criteria also include specific inclusion and exclusion conditions, such as the requirement for bony metastases and the exclusion of pregnant or breastfeeding individuals.
    Difference
    14%
    Check dated 2024-05-22T20:31:39.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:40:30.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Advanced Solid Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Solid Malignancies Clinical Trial page.